Web19 hours ago · Castle Biosciences (CSTL) (Real Time Quote from BATS) $22.81 USD +0.70 (3.17%) Updated Apr 13, 2024 02:02 PM ET Add to portfolio Zacks Rank: 3-Hold 3 … WebFind real-time CSTL - Castle Biosciences Inc stock quotes, company profile, news and forecasts from CNN Business.
Did you know?
WebThe CSL Ltd ( ASX: CSL) share price lagged the S&P/ASX 200 Index in the first quarter of 2024. Shares in the ASX 200 biotechnology company closed out 2024 trading for $287.76. When the closing ... Web14 hours ago · The CSL share price has gained 89% over the last five years to trade at $302.18 today Meanwhile, the company has paid out consistent dividends Indeed, each …
WebCastle Biosciences Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CSTL stock price. WebThe latest price target for . Castle Biosciences (NASDAQ: CSTL) was reported by Stephens & Co. on Thursday, March 2, 2024.The analyst firm set a price target for 41.00 expecting CSTL to rise to ...
WebETF News Global Markets News Expert Spotlight TipRanks Labs Earnings Reports Insights Market Breakdowns Dividend Stock News Crypto News. News . ... (CSTL) Stock Price & Analysis. Follow. 283 Followers. Portfolio. CSTL Stock Chart & Stats. Advanced Chart > ... Castle Biosciences lowest stock price was $15.58 and its highest was $47.27 in the ... WebThe 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Castlight Health Inc - Ordinary Shares - Class B 50-day moving average is $1.84.
WebApr 11, 2024 · The CSL Ltd ( ASX: CSL) share price lagged the S&P/ASX 200 Index in the first quarter of 2024. Shares in the ASX 200 biotechnology company closed out 2024 trading for $287.76. When the closing ...
WebMar 23, 2024 · CASTLE BIOSCIENCES, INC. (NASDAQ:CSTL) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share CASTLE BIOSCIENCES, INC. Nasdaq: CSTL ... hotel sai chandan puriWebMar 29, 2024 · Analyst Forecast. According to 14 analysts, the average rating for CSTL stock is "Buy." The 12-month stock price forecast is $46.79, which is an increase of 108.42% from the latest price. hotel sai balaji shirdiWebCastle Biosciences, Inc. (CSTL) Stock Price, News, Quote & History - Yahoo Finance Dow Futures +43.00 -13.00(-0.10%) Russell 2000 Futures Castle Biosciences, Inc. (CSTL) … Find the latest Castle Biosciences, Inc. (CSTL) stock discussion in Yahoo … See the company profile for Castle Biosciences, Inc. (CSTL) including … Find out the direct holders, institutional holders and mutual fund holders for … Discover historical prices for CSTL stock on Yahoo Finance. View daily, weekly or … See Castle Biosciences, Inc. (CSTL) stock analyst estimates, including earnings … Find out all the key statistics for Castle Biosciences, Inc. (CSTL), including … See Castle Biosciences, Inc. (CSTL) Environment, Social and Governance … FRIENDSWOOD, Texas, January 09, 2024--Castle Biosciences today announced … View the basic CSTL option chain and compare options of Castle Biosciences, … Find the latest Castle Biosciences, Inc. (CSTL) stock quote, history, news and … feliz 37 vueltas al solWeb2 days ago · If I opted to sell those 236 shares today they’d get me a whopping $71,817 and change. In other words, the stock would have seen me gain 7,081% on my initial … feliz 39WebMar 30, 2024 · marketbeat.com - March 27 at 6:15 AM. Castle Biosciences, Inc. (NASDAQ:CSTL) Receives $52.00 Consensus PT from Brokerages. americanbankingnews.com - March 30 at 1:34 AM. Castle Biosciences, Inc. (NASDAQ:CSTL) is largely controlled by institutional shareholders who own 85% of the … hotel sai bansi shirdiWebMar 1, 2024 · Castle Biosciences, Inc. (CSTL) came out with a quarterly loss of $0.78 per share versus the Zacks Consensus Estimate of a loss of $0.91. This compares to loss of $0.25 per share a year ago. feliz 35 anosWebCastle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that Derek Maetzold, president and chief executive officer, and Fr... feliz 38 meses mi amor